Praxis Precision Medicines, Inc.

NASDAQ:PRAX

63.02 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -39.553-26.878-24.632-34.312-37.455-41.173-43.945-60.194-68.717-58.582-44.705-36.401-27.373-25.706-16.216-11.568-8.33-7.388-10.606-8.759-8.759
Depreciation & Amortization 0.1120.1110.1090.1060.1060.1050.1020.1190.0930.0930.0390.0270.0230.020.010.010.010.010.010.0090.009
Deferred Income Tax 0-0.00200.002000000.6330.6390.5540.26100000000
Stock Based Compensation 14.4755.7265.7635.7757.5936.3666.737.6117.8866.1066.5215.44.6663.8260.9530.2850.1470.1580.2760.1170.117
Change In Working Capital 1.74-3.038-4.667-2.991-3.3365.504-8.205-5.1546.0746.42313.0770.115-3.4821.4531.1951.157-0.565-2.8992.4580.3170.317
Accounts Receivables 000000000000000000000
Change In Inventory 000000000000000000000
Change In Accounts Payables 3.589-1.299-0.894-8.9762.3144.55-1.699-1.4482.4893.2360.3231.52.2080.416-0.368-0.0790.991-0.481-0.90900
Other Working Capital -1.849-1.739-3.7735.985-5.650.954-6.506-3.7063.5853.18712.754-1.385-5.691.0371.5631.236-1.556-2.4183.3670.3170.317
Other Non Cash Items 13.750.2180.2120.2060.2460.3920.3990.4090.5550.470.4670.2920.1830.1790.1760.1720.1690.1650.1620.4340.434
Operating Cash Flow -20.586-23.861-23.215-31.214-32.846-28.806-44.919-57.209-54.109-44.857-23.962-30.013-25.722-20.228-13.882-9.944-8.569-9.954-7.7-7.883-7.883
Investing Activities:
Investments In Property Plant And Equipment 0-0.050000-0.045-0.11-0.289-0.531-0.45-0.065-0.0040.0040000-0.029-0.037-0.037
Acquisitions Net 000000000000000000000
Purchases Of Investments -91.220000000-83.02200-24.164-140.00600000000
Sales Maturities Of Investments 00053422.594483574.76110.7140000000000
Other Investing Activites -91.220053422.5944835-8.26110.714-24.164-140.00600000000
Investing Cash Flow -91.22-0.05053422.59447.95534.89-8.5510.16913.55-24.229-140.010.0040000-0.029-0.037-0.037
Financing Activities:
Debt Repayment -0.271-0.261-0.254-0.25-0.24-0.233-0.226-0.326-0.026-0.197-0.193-0.188-0.18500000000
Common Stock Issued 182.8944.0250.00169.47118.0965.2312.9620.521.3687.7130.21299.3850.276200.8860000000
Common Stock Repurchased -0.137-0.005-0.001-0.004-0.127-0.007-0.007-0.016-0.2300003000-300000
Dividends Paid 000000000000000000000
Other Financing Activities -0.1370.3620.5070.7080.5810.6290.8620.504-0.1597.7130.21299.3850.276202.064108.90623.446-3050.449-0.0584.9994.999
Financing Cash Flow 182.4864.126-0.00169.67518.075.3873.3650.5041.2097.7130.21299.3850.276202.064108.90623.446-3050.449-0.0584.9994.999
Other Information:
Effect Of Forex Changes On Cash 036.6830-36.683000000000-0.0040000000
Net Change In Cash 70.68-19.785-23.21543.46119.224-0.8256.401-21.815-61.45-26.975-10.245.143-165.456181.83695.02413.502-38.56940.495-7.787-2.922-2.922
Cash At End Of Period 151.9881.716101.501124.71681.25562.03162.85656.45578.27139.72166.695176.895131.752297.208115.37220.3486.84645.4154.9212.707-2.922